Menu
Search
|

Menu

Close
X

Merit Medical Systems Inc MMSI.OQ (NASDAQ Stock Exchange Global Select Market)

56.31 USD
-0.16 (-0.28%)
As of Jul 17
Previous Close 56.47
Open 56.55
Volume 90,136
3m Avg Volume 125,001
Today’s High 57.29
Today’s Low 56.27
52 Week High 66.28
52 Week Low 49.44
Shares Outstanding (mil) 55.00
Market Capitalization (mil) 3,106.13
Forward P/E 67.15
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.88 Mean rating from 8 analysts

KEY STATS

Revenue (mm, USD)
FY19
238
FY18
883
FY17
728
FY16
604
EPS (USD)
FY19
0.110
FY18
0.832
FY17
0.611
FY16
0.451
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
67.15
34.16
Price to Sales (TTM)
vs sector
3.38
8.16
Price to Book (MRQ)
vs sector
3.30
4.38
Price to Cash Flow (TTM)
vs sector
25.30
24.12
Total Debt to Equity (MRQ)
vs sector
40.87
18.17
LT Debt to Equity (MRQ)
vs sector
38.53
13.01
Return on Investment (TTM)
vs sector
3.51
12.64
Return on Equity (TTM)
vs sector
5.67
17.19

EXECUTIVE LEADERSHIP

Fred Lampropoulos
Chairman of the Board, President, Chief Executive Officer, Since 1987
Salary: $1,412,310.00
Bonus: $600,000.00
Raul Parra
Chief Financial Officer, Since 2018
Salary: --
Bonus: --
Joseph Wright
President - International Division, Since 2015
Salary: $473,078.00
Bonus: $225,000.00
Ronald Frost
Chief Operating Officer, Since 2014
Salary: $400,000.00
Bonus: $200,000.00
Justin Lampropoulos
Executive Vice President - Sales, Marketing and Strategy, Since 2015
Salary: $500,000.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

1600 W Merit Pkwy
SOUTH JORDAN   UT   84095-2416

Phone: +1801.2531600

Merit Medical Systems, Inc. is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices. Its endoscopy segment consists of gastroenterology and pulmonology medical devices, which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products focused in four product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, and endoscopy.

SPONSORED STORIES